A simple solution which has slashed cell line development times at Genmab

The Cell Line Development (CLD) team at Genmab, a large international biotech company working on cutting-edge oncology drugs, decided at the end of 2017 that it wanted to speed up development of the company’s growing portfolio of antibody-based therapeutics. Thanks to Solentim easy-to-implement VIPS technology, they have already halved development times with minimal effort and disruption to staff and ongoing projects.